SIGHT SCIENCES, INC. Selling, General and Administrative Expense
SIGHT SCIENCES, INC. (SGHT) reported Selling, General and Administrative Expense of $22.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- SIGHT SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $22.75M, a 4.68% decline year-over-year.
- SIGHT SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $26.84M, a 9.47% increase year-over-year.
- SIGHT SCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $19.02M, a 21.40% decline year-over-year.
- SIGHT SCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $21.75M, a 7.01% decline year-over-year.
- SIGHT SCIENCES, INC. selling, general and administrative expense for fiscal 2025 was $89.16M, a 11.57% decline from fiscal 2024.
- SIGHT SCIENCES, INC. selling, general and administrative expense for fiscal 2024 was $100.83M, a 7.41% decline from fiscal 2023.
- SIGHT SCIENCES, INC. selling, general and administrative expense for fiscal 2023 was $108.89M, a 9.30% decline from fiscal 2022.
- SIGHT SCIENCES, INC. selling, general and administrative expense for fiscal 2022 was $120.06M, a 57.59% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.75M 10-Q · filed 2026-08-05 | $49.59M 10-Q · filed 2026-08-05 | $68.61M derived: sum of 3 quarters · filed 2026-08-05 | $90.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $26.84M 10-Q · filed 2026-05-06 | $45.87M derived: sum of 2 quarters · filed 2026-05-06 | $67.61M derived: sum of 3 quarters · filed 2026-05-06 | $91.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $40.77M derived: sum of 2 quarters · filed 2026-03-04 | $64.64M derived: sum of 3 quarters · filed 2026-08-05 | $89.16M 10-K · filed 2026-03-04 |
| 2025-09-30 | $21.75M 10-Q · filed 2025-11-06 | $45.62M derived: sum of 2 quarters · filed 2026-08-05 | $70.14M 10-Q · filed 2025-11-06 | $94.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $23.87M 10-Q · filed 2026-08-05 | $48.39M 10-Q · filed 2026-08-05 | $72.59M derived: sum of 3 quarters · filed 2026-08-05 | $95.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $24.52M 10-Q · filed 2026-05-06 | $48.72M derived: sum of 2 quarters · filed 2026-05-06 | $72.11M derived: sum of 3 quarters · filed 2026-05-06 | $98.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $47.59M derived: sum of 2 quarters · filed 2026-03-04 | $74.27M derived: sum of 3 quarters · filed 2026-03-04 | $100.83M 10-K · filed 2026-03-04 |
| 2024-09-30 | $23.39M 10-Q · filed 2025-11-06 | $50.07M derived: sum of 2 quarters · filed 2025-11-06 | $76.63M 10-Q · filed 2025-11-06 | $100.29M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $26.68M 10-Q · filed 2025-08-07 | $53.24M 10-Q · filed 2025-08-07 | $76.90M derived: sum of 3 quarters · filed 2025-08-07 | $103.40M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $26.56M 10-Q · filed 2025-05-08 | $50.22M derived: sum of 2 quarters · filed 2025-05-08 | $76.72M derived: sum of 3 quarters · filed 2025-05-08 | $106.78M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $23.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $50.16M derived: sum of 2 quarters · filed 2025-03-07 | $80.22M derived: sum of 3 quarters · filed 2025-03-07 | $108.89M 10-K · filed 2025-03-07 |
| 2023-09-30 | $26.50M 10-Q · filed 2024-11-07 | $56.56M derived: sum of 2 quarters · filed 2024-11-07 | $85.23M 10-Q · filed 2024-11-07 | $113.93M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $30.06M 10-Q · filed 2024-08-02 | $58.73M 10-Q · filed 2024-08-02 | $87.43M derived: sum of 3 quarters · filed 2024-08-02 | $118.97M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $28.68M 10-Q · filed 2024-05-06 | $57.37M derived: sum of 2 quarters · filed 2024-05-06 | $88.91M derived: sum of 3 quarters · filed 2024-05-06 | $120.34M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $28.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $60.24M derived: sum of 2 quarters · filed 2024-03-13 | $91.67M derived: sum of 3 quarters · filed 2024-03-13 | $120.06M 10-K · filed 2024-03-13 |
| 2022-09-30 | $31.54M 10-Q · filed 2023-11-07 | $62.97M derived: sum of 2 quarters · filed 2023-11-07 | $91.37M 10-Q · filed 2023-11-07 | $114.46M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $31.43M 10-Q · filed 2023-08-07 | $59.83M 10-Q · filed 2023-08-07 | $82.92M derived: sum of 3 quarters · filed 2023-08-07 | $103.71M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $28.39M 10-Q · filed 2023-05-08 | $51.48M derived: sum of 2 quarters · filed 2023-05-08 | $72.28M derived: sum of 3 quarters · filed 2023-05-08 | $90.03M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $23.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $43.88M derived: sum of 2 quarters · filed 2023-03-16 | $61.64M derived: sum of 3 quarters · filed 2023-03-16 | $76.19M 10-K · filed 2023-03-16 |
| 2021-09-30 | $20.79M 10-Q · filed 2022-11-10 | $38.55M derived: sum of 2 quarters · filed 2022-11-10 | $53.10M 10-Q · filed 2022-11-10 | $65.28M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $17.76M 10-Q · filed 2022-08-11 | $32.31M 10-Q · filed 2022-08-11 | $44.48M derived: sum of 3 quarters · filed 2022-08-11 | $55.71M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $14.55M 10-Q · filed 2022-05-10 | $26.73M derived: sum of 2 quarters · filed 2022-05-10 | $37.95M derived: sum of 3 quarters · filed 2022-05-10 | $45.62M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $12.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $23.40M derived: sum of 2 quarters · filed 2022-03-24 | $31.07M derived: sum of 3 quarters · filed 2022-03-24 | $41.74M 10-K · filed 2022-03-24 |
| 2020-09-30 | $11.23M 10-Q · filed 2021-11-10 | $18.89M derived: sum of 2 quarters · filed 2021-11-10 | $29.57M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.66M 10-Q · filed 2021-08-12 | $18.34M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |